TokenPost·
Anthropic Says Mithril Drug Reached Animal Testing With AI Support
The potential treatment targets a rare muscle-wasting disease and could enter human trials as early as late 2028 if further experiments go well.
More news
- TokenPostSouth Korea Aims to Cultivate 20 AI Unicorns and One Decacorn by 2030
- CryptoSlateNovig loses court shield, and New York gambling laws strike back
- TokenPostOCC’s April Preliminary Decision Set $60 Million Floor for Coinbase Trust
- TokenPostxStocks Adds More Than 200 UK and EU Stock Tokens Through GTN
- TokenPostJPYC CEO Expects Demand to Rise as Japanese Banks Face Disruptions
- TokenPostU.S. and China Advance Plans for Direct AI Incident Channel